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Objective: To evaluate the hypothesis that a mechanical stimulus (30-min walk) will produce a change in
serum concentrations of cartilage oligomeric matrix protein (COMP) that is associated with cartilage
thickness changes on magnetic resonance imaging (MRI).
Methods: Serum COMP concentrations were measured by enzyme-linked immunosorbent assay in 17
patients (11 females, age: 59.0 9.2 years) with medial compartment knee osteoarthritis (OA) at study
entry immediately before, immediately after, 3.5 h, and 5.5 h after a 30-min walking activity. Cartilage
thickness changes in the medial femur and medial tibia were determined from MR images taken at study
entry and at 5-year follow-up. Relationships between changes in cartilage thickness and COMP levels,
with post-activity concentrations expressed as a percentage of pre-activity levels, were assessed by the
calculation of Pearson correlation coefﬁcients and by multiple linear regression analysis, with adjust-
ments for age, sex, and body mass index (BMI).
Results: Changes in COMP levels 3.5 h and 5.5 h post-activity were correlated with changes in cartilage
thickness in the medial femur and tibia at the 5-year follow-up. The results were strengthened after
analyses were adjusted for age, sex, and BMI. Neither baseline pre-activity COMP levels nor changes in
COMP levels immediately post-activity were correlated with cartilage thickness changes.
Conclusions: The results of this study support the hypothesis that a change in COMP concentration
induced by a mechanical stimulus is associated with cartilage thinning at 5 years. Mechanically-induced
changes in mechano-sensitive biomarkers should be further explored in the context of stimuluseresponse
models to improve the ability to assess OA progression.
Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.Introduction
Despite the substantial individual and societal impact of oste-
oarthritis (OA), factors affecting the natural history of the disease
are still poorly understood. Disease severity in patients with OA
does not progress at the same rate; while approximately 30e50% of
patients with knee OAwill experience increased severity, many OA
patients remain stable over time1e5. The ability to identify indi-
viduals at high risk of worsening or progression of the disease
remains an important step for improving the treatment of knee OA.: J. C. Erhart-Hledik, Depart-
1, Stanford University, Stan-
000x67677; Fax: 1-650-493-
ledik).
r Ltd on behalf of Osteoarthritis ReThe application of serum-derived biological markers (biomarkers)
offers an attractive method to determine which patients will
progress and could provide information that would enhance the
management of the disease.
Ideally, a good marker for OA would be correlated with the
changes in the clinical status of patients over time. One such sug-
gested marker is cartilage oligomeric matrix protein (COMP),
a component of the articular cartilage extracellular matrix synthe-
sized by chondrocytes6. Reports that COMP levels are higher in OA
patients than in healthy controls7e11 indicate increased cartilage
turnover and damage to the cartilage matrix12 and suggest the
potential for COMP to be a meaningful marker for OA. However, the
sensitivity of COMP as a diagnostic or prognostic marker has been
limited by the large inter-subject variability of serum levels where
there is substantial overlap between the COMP levels seen in OA and
those in healthy patients7. This individual variability in COMP levelssearch Society International.
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COMP levels for predicting structural disease progression13e20.
The fact that COMP is mechano-sensitive and plays a role in
transducing mechanical forces in the extracellular matrix to the
cells21,22 suggests the possibility that a mechanical stimulus could
be an effective approach to elevate the sensitivity of COMP as
a prognostic indicator of the health status of cartilage. The idea of
using changes in COMP levels in response to a mechanical stimulus
is supported by reports that physical activity can affect serum
COMP concentration in both healthy individuals and patients with
OA23e27. Taken together, these studies suggest that a mechanical
stimulus in the form of physical activity will induce a short-term
change in serum biomarker levels that will reﬂect the state of the
cartilage health and will be associated with disease progression.
Examining individual changes in COMP levels rather than
comparing resting levels across a population can also reduce the
sensitivity to inter-individual variations in COMP levels. Thus,
analyzing COMP in a stimuluseresponse framework28 in which
changes in COMP concentration are induced in response to
a mechanical stimulus has the potential to achieve greater efﬁ-
ciency in detecting underlying pathology (disease activity).
The purpose of this study was to evaluate the hypothesis that
the changes in serum levels of COMP in response to a mechanical
stimulus (30-min walk) will be associated with cartilage thickness
changes over a 5-year follow-up. Speciﬁcally, this study tested for
a correlation between relative changes in COMP levels and changes
in cartilage thickness. In addition, this study also tested for
a correlation between baseline resting concentrations of COMP and
cartilage thickness changes.
Patients and methods
Patients
The present study was conducted on a subset of subjects
recruited from a prior study examining changes in COMP concen-
tration following a walking exercise26. The original study included
42 patients, recruited from the orthopedic clinic at the Veterans
Affairs Palo Alto or from the community after responding to printed
advertisements, with diagnosedmedial compartment knee OA. The
Institutional Review Board approved the baseline study and
permitted contacting the subjects for future studies. Following
a second IRB approval, subjects were contacted by mail and phone
to determine eligibility for the follow-up study. Seventeen of the
original 42 patients were eligible and willing to return for testing,
and participated in this study. Of the remaining 25 patients not
tested, three had lower extremity surgery, four had total knee
replacement, three had moved to another state and were unable to
return for testing, three were unwilling to return for testing, one
was deceased, and 11 did not respond. Informed consent was ob-
tained from all participants at baseline and follow-up examina-
tions. All tested subjects met the inclusion/exclusion criteria at both
baseline and follow-up examinations. Inclusion criteria included:
age greater than 40 years; persistent medial compartment knee
joint pain; and radiographically-diagnosed medial compartment
knee OA. Exclusion criteria included: serious lower extremity (foot,
ankle, knee, back, hips) injury or surgery; diagnosed or symptom-
atic OA in other lower extremity joints; radiographic evidence of
isolated lateral compartment OA; gout or recurrent pseudogout;
age greater than 85 years; body mass index (BMI) greater than
35 kg/m2; total knee or hip replacement in either leg; and inability
to have a magnetic resonance imaging (MRI) scan. Bilateral
anterioreposterior standing full leg radiographs were obtained for
all participants to determine the index knee and to describe the
cohort. Radiographs were read blinded by an experiencedorthopedic surgeon (NJG) using the KellgreneLawrence (KL) atlas
to determine radiographic grade29.
MRI acquisition
For all subjects, an MRI was performed at baseline on the more
affected knee, as determined by KL grade, or in the case of equal KL
grade between knees, by more severe self-reported pain. The mean
(SD) time to follow-up MRI for the selected knee was 56.5 (6.3)
monthsafter thebaselineMRI.All scanswereperformedonaGeneral
Electric Signa 1.5-TeslaMRI system (GEMedical Systems,Milwaukee,
WI) using a standard transmit-receive extremity coil. High contrast
MR images of the knee were obtained using a fat-suppressed three-
dimensional (3D) spoiled gradient recalled echo (SPGR) sequence in
the sagittal plane with acquisition parameters as follows: repetition
time (TR)¼ 60 ms, echo time (TE)¼ 5 ms, ﬂip angle¼ 40, ﬁeld of
view 140140 mm, slice thickness of 1.5 mm, 60 slices, and matrix
256 256 pixels. The fat-suppressed 3D SPGR sequence is sensitive
in detecting abnormalities of hyaline cartilage in the knee30,31.
Cartilage thickness measurement
Cartilage thickness was computed over the medial femoral and
tibial surfaces using 3D image processing. The cartilage boundaries
were manually segmented by a single operator using a B-Spline
Snakes method for each image using custom software32. 3D
computer cartilage models were created and cartilage thickness
maps were calculated for the bone-cartilage layer. In denuded areas
the thickness was set to 0 mm. The coefﬁcients of variation for this
method have been previously evaluated to be 1e3%32.
The mean cartilage thickness was calculated over the total
weight-bearing area of the medial femur (Fig. 1). This area was
deﬁned as the region between the intercondylar notch and 60% of
the distance to the posterior end of the femoral condyles33. For sub-
regional thickness analysis, the medial condyle was also divided
into three sub-regions (Fig. 1; central, internal, and external) using
the method of Wirth and Eckstein34. Each of the three sub-regions
occupied 33.3% of the total subchondral bone area. The total medial
tibial plateau was divided into ﬁve sub-regions for sub-regional
analysis34 (Fig. 1; central, internal, external, anterior, and poste-
rior), with the central tibial sub-region occupying 20% of the total
subchondral bone area. Change in cartilage thickness was calcu-
lated as the difference in cartilage thickness between the 5-year
follow-up and baseline values.
Serum collection protocol
Subjects were asked to limit their physical activity for 36 h prior
to baseline testing. Tests began between 7:30 and 8:30 am, and
subjects were asked to limit their activity between the time they
woke up and their enrollment in the study. The ﬁrst blood sample
was taken after the MR collection, after subjects had rested in
a prone (MRI) or seated position for 2 h. Five-milliliter blood
samples were collected by venous puncture immediately before,
immediately after, 3.5 h, and 5.5 h after a 30-min walking exercise
(Fig. 2). For the walking exercise, patients walked at their self-
selected speed for 30 min on a level walking track. An activity
monitor (AMP331; Dynastream Innovations Inc., Cochrane, Canada)
was placed on the ankle of the subjects to record the number of
steps, cadence, and total distance walked during the walking task.
Following the walking exercise, subjects remained in a seated
position with minimal physical activity. Blood specimens were
centrifuged to separate serum, aliquoted, and frozen to 20C
within 1 h of collection, and were then transferred to 80C
freezers until analysis.
Fig. 1. Analyzed medial (A) femoral and (B) tibial sub-regions. iM: internal, cM: central,
eM: external, aM: anterior, pM: posterior.
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Serum concentrations of COMP were measured in duplicate and
in random order using a commercial sandwich-type ELISA
according to the manufacturer’s directions (AnaMar Medical AB,
Lund, Sweden). The detection limit of the assay was <0.1 unit/l
(10 units/l converts to approximately 1 mg/ml), and the intra-assay
and inter-assay coefﬁcients of variation were <1.9% and <2.7%,
respectively. All samples for any single subject were tested on the
same plate.
Statistical analysis
The ShapiroeWilk statistic was used to conﬁrm that the data
were normally distributed. COMP concentrations following the 30-
min walking exercise were compared to baseline concentrations
using repeated measures ANOVA with paired t-tests for post-hoc
comparisons. Relations between changes in cartilage thickness
and COMP levels, with post-activity concentrations expressed as
a percentage of pre-activity levels, were assessed by the calculationFig. 2. Baseline protocol. The vertical arrows indicate blood draws and the number at
the bottom indicates hour of the testing day.of Pearson correlation coefﬁcients and bymultiple linear regression
analysis, with adjustments for age, sex, and BMI. A P-value (two-
tailed) <0.05 was considered signiﬁcant. All statistical calculations
were performed with SPSS version 18.0 (SPSS Inc., Chicago, IL).Results
Participant characteristics
The participants included 11 females and six males. At baseline,
themean (SD) agewas 59.0 (9.2) years, mean BMI was 28.1 (4.6) kg/
m2, and mean KL grade was 2.2 (1.1). During the 30-min walking
exercise, the subjects took 3527 (574) steps at a cadence of 114 (10)
steps/min for a total distance of 2354 (448) m. The mean pre-
activity COMP concentration at baseline testing was 10.4 (3.2)
units/l. Compared to pre-activity levels, there was a trend toward
an increase in mean serum COMP concentration immediately after
the 30-min walking exercise (þ4.0%, P¼ 0.07; Fig. 3). COMP levels
were not signiﬁcantly different from pre-activity levels 3.5 h after
the walking activity (6.9%, P¼ 0.20; Fig. 3), but were signiﬁcantly
reduced 5.5 h after the walking activity (16.3%, P¼ 0.002; Fig. 3).
There was no association between changes in COMP levels after
exercise and either number of steps taken, cadence, or distance
walked during the 30-min walking exercise. The reductions in
cartilage thickness over the 5-year time period are given in Table I.
Signiﬁcant reductions in cartilage thickness were observed for the
medial femur (Table I).Fig. 3. Serum COMP concentrations in percent of baseline after a 30-min exercise
activity. (A) Each line represents an individual patient. (B) Average serum COMP
concentration for all subjects. * Indicates signiﬁcant difference vs pre-activity level
(P< 0.05).
Table I
Average percent change in cartilage thickness in the medial femoral and medial
tibial regions over the 5-year study period
Cartilage region Percent change in cartilage thickness P-value
Medial femur
Central 12.2% 0.003
External 4.6% 0.143
Internal 5.6% 0.032
Total 7.7% 0.005
Medial tibia
Central 5.8% 0.236
Anterior 4.3% 0.159
External 7.0% 0.154
Posterior 2.4% 0.556
Internal 3.5% 0.406
Total 4.3% 0.218
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Changes in COMP levels 3.5 h post-activity were negatively
correlated with changes in medial cartilage thickness in the central
femur (R¼0.483, P¼ 0.049) and anterior (R¼0.733, P¼ 0.001;
Fig. 4) and external tibia regions (R¼0.603, P¼ 0.010). Similarly,
changes in COMP levels 5.5 h post-activity were negatively asso-
ciated with changes in medial cartilage thickness in the central
femur (R¼0.526, P¼ 0.030) and anterior (R¼0.612, P¼ 0.009)
and external tibia regions (R¼0.601, P¼ 0.011). The results were
strengthened after the analyses were adjusted for age, sex, and BMI
(Table II). After adjustment, in addition to the above relationships,
changes in COMP levels 3.5 h post-activity were negatively corre-
lated with changes in the central (P¼ 0.047) and total medial tibial
(P¼ 0.024) cartilage thickness. Further, after adjustment, changes
in COMP levels 5.5 h post-activity were negatively correlated with
changes in cartilage thickness in the total medial femur (P¼ 0.029)
and total medial tibia (P¼ 0.050). All signiﬁcant correlations were
negative indicating that higher relative post-activity COMP levels
were associated with greater reduction in cartilage thickness over
the 5-year test period. Neither baseline pre-activity COMP levels
nor changes in COMP levels immediately post-activity predicted
5-year cartilage thickness changes in either themedial femur or the
medial tibia (Table II).Discussion
The results of this study indicate that baseline changes in serum
COMP levels in response to a 30-min walking stimulus are associ-
ated with cartilage changes on MRI in medial compartment kneeFig. 4. Association between change in COMP concentration (3.5 h post-activity) and
5-year change in cartilage thickness for the anterior medial tibia.OA patients over a 5-year period. In contrast, baseline resting levels
of COMP were not associated with changes in cartilage thickness
over 5 years. These results suggest that a stimuluseresponse
model, in which a change in COMP concentration is induced by
a mechanical stimulus, may be a useful diagnostic tool for evalu-
ating the progression of OA.
COMP has been regarded as a potential biomarker for the
prognosis of OA progression13e20. However, as previously noted20,
the large variability in COMP concentrations between individuals
limits its sensitivity for detecting small changes in disease state
over time. Hence, it is not surprising that the results of this study
were consistent with other studies14,15,17,19 where individual base-
line pre-activity concentrations of COMP were not correlated with
cartilage thickness changes over a 5-year time period. However,
examining COMP levels in response to a mechanical stimulus
appears to normalize the response of COMP to individual variations
in resting levels and produces a short-term change in COMP
concentration that is signiﬁcantly associated with long-term
morphological changes in cartilage.
The results of this study indicating that the changes in COMP
levels following a mechanical stimulus are indicative of increased
rates of cartilage degradation are consistent with some of the
fundamental properties of COMP. COMP is a large (a 524 kDa) ﬁve-
armed member of the thrombospondin family of calcium-binding
proteins found in the articular cartilage extracellular matrix6,35. It
has been reported that COMP plays an important role in regulating
collagen ﬁbril assembly and stabilizing the cartilagematrix to allow
for its load-bearing function36,37. In addition, COMP is associated
with transducing matrix forces to the cells21,22. The 30-minwalking
activity was sufﬁcient for altering serum levels of COMP in patients
with medial compartment knee OA as shown in previous
studies23,25,26. Thus, the stimuluseresponse framework utilizes the
mechano-sensitivity of COMP to enhance its prognostic abilities.
The mechanical stimulus used in this study produced a large
spread in the response of COMP 3.5 h and 5.5 h post-activity that
appears to reﬂect the individual state of the disease as there were
signiﬁcant associations between changes in COMP concentration
and 5-year cartilage thickness changes. Our data suggest that
patients with higher relative COMP levels 3.5 h and 5.5 h after
a 30-min walking exercise have greater cartilage loss after a 5-year
time period. The changes in COMP levels that are associated with
cartilage degradation appear to be caused by altered metabolic
activity rather than diffusion due to walking because of the 3-h
time lag between the walking activity and the predictive serum
COMP changes. This observation is consistent with reports that
COMP is released in response to damage in the cartilagematrix35,38,
either due to increased synthesis of COMP39 or release of bound
proteins from the extracellular matrix27. There is also evidence that
production of COMP is up-regulated by proinﬂammatory cytokines,
which may be present in OA joints40. Thus abnormal tissue
metabolism in response to the walking exercise may indicate
greater disease activity, which was indicated by cartilage degen-
eration 5 years later.
The stimuluseresponse model used in this study demonstrated
the ability of a relatively short mechanical stimulus (30-min walk)
to produce a short-term biological response in biomarker concen-
tration. Similar to a cardiac stress test, in which a controlled exer-
cise stimulus is used to produce a physiological response to reveal
underlying pathology that cannot be detected without a provoca-
tive stimulus, the stimuluseresponse model used in this study was
able to use the relative changes in COMP levels in response to the
walking activity to detect cartilage thinning at a 5-year follow-up.
These results suggest that changes in COMP may serve as a poten-
tial biomarker for the detection of patients at risk of progressive
disease.
Table II
Associations between baseline COMP pre-activity concentration or post-activity changes and cartilage thickness changes over the 5-year test period. The coefﬁcient (top) and
the level of signiﬁcance (P-value: bottom) are reported for each pair. Bold indicates signiﬁcant predictors
Pearson correlation coefﬁcient Multiple linear regression coefﬁcient*
Pre-activity concentration
(units/l)
Post-activity changes (% of pre-activity level) Pre-activity concentration
(units/l)
Post-activity changes (% of pre-activity level)
0.0 h 3.5 h 5.5 h 0.0 h 3.5 h 5.5 h
Medial femur
Central 0.046 0.377 L0.483 L0.526 0.005 0.017 L0.008 L0.010
0.860 0.135 0.049 0.030 0.849 0.105 0.038 0.020
External 0.093 0.421 0.462 0.401 0.006 0.009 0.005 0.005
0.723 0.092 0.062 0.111 0.724 0.186 0.059 0.098
Internal 0.097 0.259 0.239 0.023 0.002 0.011 0.0002 0.003
0.712 0.315 0.356 0.930 0.919 0.133 0.935 0.296
Total 0.013 0.441 0.317 0.417 0.004 0.012 0.004 L0.006
0.959 0.076 0.214 0.095 0.808 0.061 0.099 0.029
Medial tibia
Central 0.132 0.299 0.375 0.282 0.014 0.004 L0.008 0.008
0.614 0.244 0.138 0.272 0.599 0.762 0.047 0.082
Anterior 0.424 0.294 L0.733 L0.612 0.027 0.003 L0.008 L0.008
0.090 0.253 0.001 0.009 0.099 0.707 0.000 0.005
External 0.277 0.393 L0.603 L0.601 0.022 0.012 L0.010 L0.012
0.282 0.119 0.010 0.011 0.323 0.213 0.001 0.000
Posterior 0.042 0.152 0.260 0.177 0.009 0.005 0.004 0.003
0.873 0.560 0.313 0.496 0.650 0.600 0.258 0.405
Internal 0.104 0.091 0.039 0.042 0.0002 0.007 0.0003 0.001
0.690 0.729 0.883 0.873 0.994 0.591 0.950 0.914
Total 0.181 0.286 0.452 0.366 0.016 0.0001 L0.006 L0.006
0.488 0.265 0.069 0.149 0.371 0.988 0.024 0.050
* Unstandardized coefﬁcient from multiple regression adjusted for age, sex, and BMI.
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several limitations. While the sample size in this early investigation
was small, the fact that for all time points and all cartilage regions
with a statistically signiﬁcant association greater cartilage thinning
was associated with higher COMP concentration as a percent of
pre-activity levels suggests that the results describe a real
phenomenon. Moreover, the regions with statistically signiﬁcant
correlations are consistent with regions identiﬁed in large cohort
studies as being more prone to thickness alterations with OA41,42.
COMP levels were measured in serum rather than in synovial ﬂuid,
and serum levels of COMP may have originated from tissues other
than articular cartilage at the knee, such as ligaments, tendon, and
menisci43 or from other joints. However, subject recruitment was
limited to those without symptoms of the other lower extremity
joints, and the concentration of COMP in non-articular tissues is
very low when compared with those in cartilage and meniscus11.
Thus, the COMP levels analyzed in this study likely reﬂect the
activity of the affected knee joints. Future larger studies could
further investigate the effect of gender differences in associations
between changes in COMP and changes in cartilage, as serum COMP
levels have been found to vary by sex44. Finally, our study investi-
gated only changes in cartilage thickness over the 5-year study
period and did not evaluate other MRI features such as osteophytes
or bone marrow lesions which could be incorporated into future
studies.
In conclusion, the results of this study suggest a paradigm shift
for the usability of biomarkers in OA research. The
stimuluseresponse model appears to induce meaningful short-
term changes in biomarker concentrations that would not be
detectable based on resting levels, and reduces the inter-subject
variability because each subject is evaluated relative to their own
baseline resting value. Speciﬁcally, the results of the study
demonstrate that a change in COMP concentration induced by
a mechanical stimulus is associated with cartilage thinning 5 years
later, suggesting that mechanically-induced changes in mechano-
sensitive biomarker concentrations, rather than single resting
biomarker concentrations, should be further explored in the searchfor diagnostic tools for OA presence and progression in patients
with OA and in individuals at a high risk for developing OA.
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